[Results of primary angioplasty in patients with multivessel disease]
- PMID: 9711102
- DOI: 10.1016/s0300-8932(98)74788-8
[Results of primary angioplasty in patients with multivessel disease]
Abstract
Introduction: In patients with acute myocardial infarction treated with primary angioplasty, multivessel disease is associated with a higher mortality. However, if higher mortality is simply due to a higher prevalence of cardiogenic shock or if multivessel disease is an independent risk factor remains unclear.
Objectives: To study if multivessel disease constitute an independent prognostic factor in patients with acute myocardial infarction treated with primary angioplasty, and to ascertain possible mechanisms contributing to the worse prognosis found in these patients.
Patients and methods: Between august 1991 and october 1996, 312 patients with acute myocardial infarction were treated with primary angioplasty in our center. Characteristics and in-hospital outcome of patients with or without multivessel disease were compared.
Results: Patients with multivessel disease (n = 158; 51%) were older (64 +/- 11 vs 61 +/- 13 years; p = 0.017), less often smokers (60% vs. 76%; p = 0.006) and had a higher prevalence of diabetes (35% vs. 20%; p = 0.007), hypertension (54% vs. 39%; p = 0.012), prior acute myocardial infarction (29% vs. 5%; p < 0.001), prior coronary bypass (2% vs. 0%; p = 0.042) and Killip class IV at admission (19% vs. 8%; p < 0.001). Angiographic success rate was not different in patients with or without multivessel disease (89% vs. 92%; NS). Patients with multivessel disease had a higher in-hospital mortality (21% vs. 7%; p < 0.001), need of revascularization (17% vs. 3%; p < 0.001) and incidence of severe mitral regurgitation, (5% vs. 0%; p < 0.001), second or third atrioventricular blockade (10% vs. 1%; p < 0.001) and severe bleeding (4% vs. 1%; p = 0.089). After excluding patients with Killip class III or IV at admission, mortality was also higher in patients with multivessel disease (9% vs. 2%; p = 0.009). Multivariate analysis showed the following independent risk factors for mortality: age > 65 years, Killip class IV and multivessel disease.
Conclusions: In patients with acute myocardial infarction treated with primary angioplasty, multivessel disease is associated with higher mortality. This is due not only to a higher prevalence of cardiogenic shock at admission, but also to a worse baseline profile, a higher incidence of complications and a more frequent need of revascularization.
Similar articles
-
In-hospital clinical outcome in elderly patients with acute myocardial infarction treated with primary angioplasty.Ital Heart J. 2003 Mar;4(3):193-8. Ital Heart J. 2003. PMID: 12784746
-
Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.J Am Coll Cardiol. 1993 Oct;22(4):1060-7. doi: 10.1016/0735-1097(93)90416-x. J Am Coll Cardiol. 1993. PMID: 8409041 Clinical Trial.
-
Prognostic impact of a chronic occlusion in a noninfarct vessel in patients with acute myocardial infarction and multivessel disease undergoing primary percutaneous coronary intervention.J Invasive Cardiol. 2006 Jan;18(1):16-9. J Invasive Cardiol. 2006. PMID: 16391378
-
Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock.J Am Coll Cardiol. 1992 Mar 1;19(3):639-46. doi: 10.1016/s0735-1097(10)80285-2. J Am Coll Cardiol. 1992. PMID: 1538022 Review.
-
Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.Tex Heart Inst J. 1995;22(2):145-61. Tex Heart Inst J. 1995. PMID: 7647598 Free PMC article. Review.
Cited by
-
Complete infarct-related artery revascularization in acute myocardial infarction patients. CORAMI Registry.Postepy Kardiol Interwencyjnej. 2015;11(2):84-8. doi: 10.5114/pwki.2015.52279. Epub 2015 Jun 19. Postepy Kardiol Interwencyjnej. 2015. PMID: 26161098 Free PMC article.
-
Percutaneous treatment in acute coronary syndromes.World J Cardiol. 2011 Oct 26;3(10):315-21. doi: 10.4330/wjc.v3.i10.315. World J Cardiol. 2011. PMID: 22053219 Free PMC article.
-
The optimal percutaneous coronary intervention strategy for patients with ST-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis.Ther Adv Chronic Dis. 2022 Mar 10;13:20406223221078088. doi: 10.1177/20406223221078088. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35295615 Free PMC article.
-
Does multivessel revascularization fit all patients with STEMI and multivessel coronary artery disease? A systematic review and meta-analysis.Int J Cardiol Heart Vasc. 2021 Jun 11;35:100813. doi: 10.1016/j.ijcha.2021.100813. eCollection 2021 Aug. Int J Cardiol Heart Vasc. 2021. PMID: 34169144 Free PMC article. Review.
-
The impact of SYNTAX score of non-infarct-related artery on long- term outcome among patients with acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.PLoS One. 2014 Oct 10;9(10):e109828. doi: 10.1371/journal.pone.0109828. eCollection 2014. PLoS One. 2014. PMID: 25303079 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous